Skip to main content

Table 6 GRADE assessment of included outcomes for PDRI and P-PASS

From: Risk indices predicting graft use, graft and patient survival in solid pancreas transplantation: a systematic review

Outcome Risk index Studies^ GRADE quality Footnotes* Interpretation
1-year pancreas survival PDRI as a continuous score 4
VERY LOW
2 studies demonstrated an association with outcome
Downgraded for:
Outcomes differing between studies (INCONSISTENCY)
Very low quality evidence that PDRI as a continuous variable is associated with 1-year pancreas survival
  PDRI as quintiles 4
LOW
3 of 4 studies demonstrated an association with the outcome
Association with SPK transplants in 2 studies
Low quality evidence that PDRI in quartiles is associated with 1-year pancreas survival (particularly SPK transplants)
  PDRI as categorical model (various risk groups) 5
VERY LOW
1 of 5 studies demonstrated an association with outcome
Downgraded for:
Differing PDRI risk groups (INDIRECTNESS)
Outcomes differing between studies (INCONSISTENCY)
Small total event rate < 300 (IMPRECISION)
Very low quality evidence that PDRI as a categorical model (by various risk groups) is associated with 1-year pancreas survival
1-year patient survival PDRI as tertiles 1
VERY LOW
No association with outcome
Downgraded for:
Small number of studies (IMPRECISION)
Very low quality evidence that PDRI by tertiles is associated with 1-year patient survival
Donor pancreas acceptance P-PASS < 17vs ≥ 17 4
LOW
All studies demonstrated an association with outcome Low quality evidence that P-PASS is associated with donor pancreas acceptance
  1. *No pooling of discrimination metrics or other effect estimates unless otherwise stated. All outcome evidence was downgraded at baseline due to the observational nature of the studies as well as their risk of bias
  2. PDRI pancreas donor risk index, P-PASS pre-procurement pancreas suitability score, SPK simultaneous pancreas-kidney transplant